Release Date: 27/11/14 10:40 Summary: Managing Director's address to AGM Price Sensitive: No Download Document 764.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%